Gabasan, Faustino A.
HRN: 26-54-42 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/17/2025
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
01/17/2025
01/24/2025
IVTT
1.5g
Q8H
CAP-MR
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes